Status:
COMPLETED
Intraoperative Endovascular Treatment Via the Ligamentum Teres Hepatis in Liver Transplantation for Yerdel Grade Ⅲ/IV Portal Vein Thrombosis: A Safe and Effective Strategy
Lead Sponsor:
Chiyi Chen
Conditions:
Liver Transplantation
Endovascular Treatment
Eligibility:
All Genders
18+ years
Brief Summary
Background: To evaluate the safety and efficacy of intraoperative endovascular treatment (EVT) using the donor ligamentum teres hepatis (LTH) approach for Yerdel grade III/IV portal vein thrombosis (P...
Eligibility Criteria
Inclusion
- Adult patients (aged ≥18 years).
- Patients underwent deceased-donor liver transplantation.
- At Tianjin First Central Hospital between February 2016 and December 2024.
- Identified recipients with Yerdel grade III/IV PVT, which was confirmed by multiphase contrast-enhanced CT, indirect portography, and intraoperative evaluation
Exclusion
- Exclusion criteria were living-donor and split-liver procedures.
- All procedures were performed using classic orthotopic transplantations.
Key Trial Info
Start Date :
February 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2025
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT07192653
Start Date
February 1 2016
End Date
April 1 2025
Last Update
September 25 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.